In this section you can read all the latest news about counterfeit and substandard medicines from around Europe and the world.
PRESS RELEASE: Nanomedicines and Nanosimilars — The EU urgently needs a Robust Centralised Regulatory Framework to Enhance Patient Safety
Nanomedicines are medicinal products of at least one dimension in the nanoscale ranges – from 1nm to 100nm. They enhance the way in which medicines
EVENT: Preventing Medication errors across European hospitals to protect patient safety: Launch of the White Paper on Medication Errors and Traceability – 22 March 2022 – 11:30 to 13:30 CET
The European Alliance for Access to Safe Medicines (EAASM) invites you to join its Parliament roundtable debate entitled “Preventing Medication errors across European hospitals to protect patient
EVENT SUMMARY: EU Parliament Roundtable webinar on Nanomedicines – 30 November 2021
Event summary of “Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process” held as a live webinar on 30th November 2021 10.00-11.30
PRESS RELEASE: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process
Nanomedicines enhance the way that medicines target and reach areas of disease within the body, opening up new therapeutic options. They offer potential solutions for